OxyHealth Vitaeris 320
FDA-cleared soft-shell chamber, the most-installed home HBOT unit in the US. Operates at 1.3–1.4 ATA — useful for recovery and mitochondrial endpoints, below the Efrati protocol pressure for senescence work.
Shop OxyHealth ↗Grade B — Tel Aviv telomere-and-senescence RCT pushed HBOT into longevity conversations; protocol matters.
Hyperbaric oxygen therapy at 2.0 ATA delivered as 40 daily sessions in Shai Efrati's 2020 Tel Aviv trial produced telomere elongation and senescent-cell reduction in older adults. The protocol — 60-minute sessions, intermittent 100% O2 with 5-minute air breaks — is replicable and is now offered in dozens of US clinics. Lower-pressure (1.3 ATA) soft chambers used by most home buyers do not match the trial protocol; clinical-grade results require clinical-grade pressure.
FDA-cleared soft-shell chamber, the most-installed home HBOT unit in the US. Operates at 1.3–1.4 ATA — useful for recovery and mitochondrial endpoints, below the Efrati protocol pressure for senescence work.
Shop OxyHealth ↗Yes. The Efrati telomere and senescence data is on 2.0 ATA hard-chamber protocols. Soft-chamber 1.3 ATA is useful for mitochondrial and recovery endpoints but is not interchangeable with the published longevity results.
Efrati's protocol is 40 sessions, 5 days a week for 8 weeks. Shorter courses produce some benefit but the dose-response in the trial was real.
Mobile chamber services exist for in-home concierge HBOT. Pricing varies widely — confirm the actual operating pressure before booking.
Direct PubMed links to the strongest published human studies behind this category. We update these as new trials emerge. Citations are educational — not endorsements of any specific brand or treatment.